Continuation of Treatment in Children With ADHD: A Multicenter Turkish Sample Study.

IF 2.7 3区医学 Q2 PSYCHIATRY

Journal of Attention Disorders Pub Date : 2024-09-01 Epub Date: 2024-01-31 DOI:10.1177/10870547231222021

Saliha Baykal, Cansu Çobanoğlu Osmanlı, Abdullah Bozkurt, Bedia Sultan Önal, Berkan Şahin, Müge Karaçizmeli, Ayşegül Öz Gazi, Koray Karabekiroğlu

{"title":"Continuation of Treatment in Children With ADHD: A Multicenter Turkish Sample Study.","authors":"Saliha Baykal, Cansu Çobanoğlu Osmanlı, Abdullah Bozkurt, Bedia Sultan Önal, Berkan Şahin, Müge Karaçizmeli, Ayşegül Öz Gazi, Koray Karabekiroğlu","doi":"10.1177/10870547231222021","DOIUrl":null,"url":null,"abstract":"Objectives: The aim of this study was to investigate the variables that may affect treatment continuation in children aged 6 to 12 years who were newly diagnosed with ADHD.Methods: A total of 132 children diagnosed with ADHD and their parents participated in the study. Sociodemographic and clinical risk factors affecting continuation of treatment were examined using logistic regression analysis.Results: Multiple model examination revealed that greater age increased the risk of treatment discontinuation 1.824 times (p = .003) while a lower total length of paternal education increased the risk of discontinuation (1/0.835) 1.198 times (p = .022). Other variables emerging as significant in the univariate model lost that significance in the multiple model.Conclusions: Understanding the variables associated with medication discontinuation in ADHD in different populations and taking these variables into account in the development of health policies, will be useful in improving the long-term devastating effects of the disorder.","PeriodicalId":15237,"journal":{"name":"Journal of Attention Disorders","volume":" ","pages":"1415-1424"},"PeriodicalIF":2.7000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Attention Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10870547231222021","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/31 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: The aim of this study was to investigate the variables that may affect treatment continuation in children aged 6 to 12 years who were newly diagnosed with ADHD.

Methods: A total of 132 children diagnosed with ADHD and their parents participated in the study. Sociodemographic and clinical risk factors affecting continuation of treatment were examined using logistic regression analysis.

Results: Multiple model examination revealed that greater age increased the risk of treatment discontinuation 1.824 times (p = .003) while a lower total length of paternal education increased the risk of discontinuation (1/0.835) 1.198 times (p = .022). Other variables emerging as significant in the univariate model lost that significance in the multiple model.

Conclusions: Understanding the variables associated with medication discontinuation in ADHD in different populations and taking these variables into account in the development of health policies, will be useful in improving the long-term devastating effects of the disorder.

查看原文本刊更多论文

多动症儿童的持续治疗：土耳其多中心样本研究

研究目的本研究旨在调查可能影响新诊断为多动症的6至12岁儿童继续接受治疗的变量：共有132名被诊断为多动症的儿童及其家长参加了研究。采用逻辑回归分析法研究了影响继续治疗的社会人口学和临床风险因素：多重模型检查显示，年龄越大，中断治疗的风险增加 1.824 倍（p = .003），而父亲受教育的总时间越短，中断治疗的风险（1/0.835）增加 1.198 倍（p = .022）。在单变量模型中具有显著性的其他变量在多重模型中失去了显著性：了解不同人群中与多动症停药相关的变量，并在制定医疗政策时考虑到这些变量，将有助于改善该疾病的长期破坏性影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Attention Disorders PSYCHIATRY-

CiteScore

7.60

自引率

6.70%

发文量

审稿时长

6-12 weeks

期刊介绍： Journal of Attention Disorders (JAD) focuses on basic and applied science concerning attention and related functions in children, adolescents, and adults. JAD publishes articles on diagnosis, comorbidity, neuropsychological functioning, psychopharmacology, and psychosocial issues. The journal also addresses practice, policy, and theory, as well as review articles, commentaries, in-depth analyses, empirical research articles, and case presentations or program evaluations.